Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health.
| Autor: | Robers MV; Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona., Amezcua L; Department of Neurology, Los Angeles, California, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Current opinion in neurology [Curr Opin Neurol] 2024 Jun 01; Vol. 37 (3), pp. 245-251. Date of Electronic Publication: 2024 Mar 20. |
| DOI: | 10.1097/WCO.0000000000001264 |
| Abstrakt: | Purpose of Review: We discuss racial and ethnic disparities in multiple sclerosis (MS), outcomes, and social determinants of health (SDoH). We also provide essential considerations needed to bridge the gap in inequalities, including broader representation of racial and ethnic people in clinical trials and research in general and the inclusion of better measures of living conditions. Recent Findings: The incidence and prevalence of MS have become more diverse in the USA. There is increased recognition that racial and ethnic health disparities and inequities exist due to adverse social conditions. Clinical trials have failed to be inclusive and diverse. Training in health disparity is an essential priority of funding sources, and designing clinical trials that consider the barriers these populations face can close significant gaps. Summary: The incidence, prevalence, and awareness of MS have seen an incline in diverse racial and ethnic populations. Health disparities exist in MS with Black, Hispanic, and indigenous populations appearing to have worse outcomes. SDoH play a significant role in causing these health disparities. Accessibility to clinical trials and treatment are barriers these populations face. Strategic and earnest interventions considering SDoH are critically needed to develop solutions that collectively improve health and MS care for all. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|